Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation

European Journal of Cardio-thoracic Surgery

Volumn 29, Issue 2, 2006, Pages 210-215

  Bittner, Hartmuth B ^a   Richter, Markus ^a   Kuntze, Thomas ^a   Rahmel, Axel ^a   Dahlberg, Peter ^b   Hertz, Marshall ^b   Mohr, Friedrich W ^a   Van Raemdonck, D ^c   Yonan, N ^c   Aharinejad, S ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NONE

Author keywords

Clinical lung transplantation; Graft failure; Ischemia reperfusion injury

Indexed keywords

APROTININ; DEXTRAN; EURO COLLINS SOLUTION;

ADULT; ALLOGRAFT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG INHIBITION; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HUMAN; ISCHEMIA; LUNG ARTERY PRESSURE; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REPERFUSION INJURY;

ADULT; ANALYSIS OF VARIANCE; APROTININ; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; FEMALE; GRAFT SURVIVAL; HUMANS; LUNG; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; REPERFUSION INJURY; RETROSPECTIVE STUDIES; SERINE PROTEINASE INHIBITORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 31044451953     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2005.12.001     Document Type: Conference Paper

References (24)

1. J.D. Cooper, G.A. Patterson, and E.P. Trulock Results of 131 consecutive single and bilateral lung transplant recipients. Washington University Lung Transplant Group J Thorac Cardiovasc Surg 107 2 1994 460 471
2. R.F. Roberts, G.P. Nishanian, J.N. Carey, S.H. Darbinian, J.D. Kim, Y. Sakamaki, J.Y. Chang, V.A. Starnes, and M.L. Barr Addition of aprotinin to organ preservation solutions decreases lung reperfusion injury Ann Thorac Surg 66 1998 225 230
3. H.B. Bittner, J. Dunitz, M. Hertz, R.M. Bolman III, and S.J. Park Hyperacute rejection in single lung transplantation - case report of successful management by means of plasmapheresis and antithymocyte globulin treatment Transplantation 71 2000 649 651
4. M.E. Prekker, D.S. Nath, A.C. Johnson, A.R. Walker, M. Hertz, and P.S. Dahlberg Validation of the proposed ISHLT grading system for primary graft dysfunction following lung transplantation J Heart Lung Transplant 24 2s1 2005 S72
5. T.M. Egan, L.R. Kaiser, and J.D. Cooper Lung transplantation Curr Probl Sur 26 10 1989 675 751
6. S.U. Khan, J. Salloum, P.B. O'Donovan, E.J. Mascha, A.C. Mehta, M.A. Matthay, and A.C. Arroliga Acute pulmonary edema after lung transplantation Chest 116 1999 187 194
7. R.C. King, Binns OAR, F. Rodriguez, R.C. Kanithanon, T.M. Daniel, W.D. Spotnitz, C.G. Tribble, and I.L. Kron Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation Ann Thorac Surg 69 2000 1681 1685
8. H.B. Bittner, S.W. Kendall, E.P. Chen, R.D. Davis, and P. Van Trigt The effects of brain death on cardiopulmonary hemodynamics and pulmonary blood flow characteristics Chest 108 1995 1358 1363
9. H.B. Bittner, E.P. Chen, S.W. Kendall, and P. Van Trigt The combined effects of brain death and cardiac graft preservation on cardiopulmonary hemodynamics and function prior to and following subsequent cardiac transplantation J Heart Lung Transplant 15 1996 764 777
10. S. Steen, P.O. Kimblad, T. Sjoberg, L. Lindberg, R. Ingemasson, and G. Massa Safe lung preservation for twenty-four hours with Perfadex Ann Thorac Surg 57 2 1994 450 457
11. M. Strueber, M. Wilhelmi, W. Harringer, J. Niedermeyer, M. Anssar, A. Kuensebeck, J.D. Schmitto, and A. Haverich Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation Eur J Cardiothorac Surg 19 2 2001 190 194
12. T.M. Aziz, M.I. Burgess, P.S. Haselton, N.A. Yonan, and I.V. Hutchinson Perfadex for clinical lung procurement: is it an advance? Ann Thorac Surg 75 3 2003 990 995
13. S.M. Fiser, C.G. Tribble, S.M. Long, A.K. Kaza, J.T. Cope, V.E. Laubach, J.A. Kern, and I.L. Kron Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response J Thorac Cardiovasc Surg 121 2001 1069 1075
14. R.J. Novick, K.E. Gehman, I.S. Ali, and J. Lee Lung preservation: the importance of endothelial and alveolar type II cell integrity Ann Thorac Surg 62 1996 302 314
15. G. Asimakopoulos, R. Thompson, S. Nourshargh, E.A. Lidington, J.C. Mason, C.P. Ratnatunga, D.O. Haskard, K.M. Taylor, and R.C. Landis An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation J Thorac Cardiovasc Surg 120 2000 361 369
16. M. de Perrot, Y. Sekine, S. Fischer, T.K. Waddell, K. McRae, M. Liu, D.A. Wigle, and S. Keshavjee Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation Am J Respir Crit Care Med 165 2002 211 215
17. P.G. Jorens, J. Van Damme, W. De Backer, L. Bossaert, R.F. De Jongh, A.G. Herman, and M. Rampart Interleukin-8 in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS Cytokine 4 1992 592 597
18. R. Davis, and R. Whittington Aprotinin: a review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery Drugs 49 1995 954 983
19. G.E. Hill, A. Alonso, J.R. Spurzem, A.H. Stammers, and R.A. Robbins Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans J Thorac Cardiovasc Surg 110 1995 1658 1662
20. G.E. Hill, R. Pohorecki, A. Alonso, S.I. Rennard, and R.A. Robbins Aprotinin reduces interleukin-8 production and lung neutrophil accumulation after cardiopulmonary bypass Anesth Analg 83 1996 696 700
21. H.E. Gilliland, M.A. Armstrong, S. Uprichard, G. Clarke, and T.J. McMurray The effect of aprotinin on interleukin-8 concentration and leukocyte adhesion molecule expression in an isolated cardiopulmonary bypass system Anaesthesia 54 1999 427 433
22. M.A. Mathias, C.G. Tribble, J.F. Dietz, R.P. Nguyen, K.S. Shockey, J.A. Kern, and I.L. Kron Aprotinin improves pulmonary function during reperfusion in an isolated lung model Ann Thorac Surg 70 2000 1671 1674
23. S. Eren, H. Esme, A.E. Balci, O. Cakir, H. Buyukbayram, M.N. Eren, L. Erdinc, and O. Satici The effect of aprotinin on ischemia-reperfusion injury in an in situ normothermic ischemic lung model Eur J Cardiothorac Surg 23 2003 60 65
24. Y.J. Gu, A.J. De Vries, P. Vos, P.W. Boonstra, and W.V. Oeveren Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit Ann Thorac Surg 67 1999 604 609